-transparent.png){kind=logo}
Streptozotocin (NSC-85998), a nitrosourea antibiotic, was given to 18 children with acute lymphocytic leukemia in relapse in a dose of 500 mg/m2/day intravenously every day for five days. There were no responses in 14 fully evaluable patients. The principal toxicity consisted of gastrointestinal disturbances. Based on our findings and those of others in adults, steptozotocin appears to play no role in the management of acute lymphocytic leukemia.
Related Publications
P G Dyment, and
R V Iyer, and
S K Morgan, and
C L Sexauer
December 1970,
Cancer chemotherapy reports,
P G Dyment, and
R V Iyer, and
S K Morgan, and
C L Sexauer
January 1974,
Cancer chemotherapy reports,
P G Dyment, and
R V Iyer, and
S K Morgan, and
C L Sexauer
January 1983,
Medical and pediatric oncology,
P G Dyment, and
R V Iyer, and
S K Morgan, and
C L Sexauer
January 1983,
Investigational new drugs,
P G Dyment, and
R V Iyer, and
S K Morgan, and
C L Sexauer
November 1981,
Cancer research,
P G Dyment, and
R V Iyer, and
S K Morgan, and
C L Sexauer
January 1975,
Cancer chemotherapy reports,
P G Dyment, and
R V Iyer, and
S K Morgan, and
C L Sexauer
January 1975,
Cancer chemotherapy reports,
P G Dyment, and
R V Iyer, and
S K Morgan, and
C L Sexauer
September 1968,
Cancer chemotherapy reports,
P G Dyment, and
R V Iyer, and
S K Morgan, and
C L Sexauer
January 1975,
Cancer chemotherapy reports,
P G Dyment, and
R V Iyer, and
S K Morgan, and
C L Sexauer
September 1983,
Cancer,
